Albumod
Affibody molecule: A molecule that can detect breast cancer
By AWA | Posted on October 31, 2018
Every month is breast cancer awareness month for Swedish Biopharmaceutical R&D company Affibody, which has developed unique molecular technologies to localise cancerous tumours and individualise drug treatment for patients Director of Alliance and IP Management at Affibody Caroline Ekblad has been with the Solna based company since 2007. She started out working with research, but...
Filed under: Interviews
Tags: Affibody, Albumod, biopharmaceuticals, breast cancer, cancer, diagnostics, Intellectual Property, molecules, patents
Recent contributors
Partner, European Patent Attorney
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
